HIV and AIDS

As a former research associate in the Bristol Myers-Squibb (BMS) virology department, I worked in conjunction with our chemistry department on HIV protease research. Most of the sorts of questions posed by the article by Robert Root- Bernstein in the April 4, 1994, issue of The Scientist [page 1] are not addressed by BMS or most pharmaceutical companies. Their focus tends to be exclusively drug discovery, meaning groups work on enzy

Written bySusan Jeffrey
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

As a former research associate in the Bristol Myers-Squibb (BMS) virology department, I worked in conjunction with our chemistry department on HIV protease research. Most of the sorts of questions posed by the article by Robert Root- Bernstein in the April 4, 1994, issue of The Scientist [page 1] are not addressed by BMS or most pharmaceutical companies. Their focus tends to be exclusively drug discovery, meaning groups work on enzymes of HIV and either screen for or design inhibitors to test as potential drug candidates. Unfortunately, there is a lot of information gained in the testing that is usually not used, published, or shared. A potential protease inhibitor takes forever to gain any sort of publication, and promising leads are often dropped because they are too long-term or need too much study and modification.

A task force to consolidate this information would indeed be useful and, in my opinion, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems

The Scientist Placeholder Image

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity 

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series